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Should we screen for intracranial aneurysms (IAs)
in systemic hypertension at the time of cardiac
magnetic resonance (CMR)?
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Emma C Hart5,2, Angus K Nightingale5, Julian F Paton5,2, Nathan E Manghat1
From 18th Annual SCMR Scientific Sessions
Nice, France. 4-7 February 2015
Background
IAs are detected in 2.3% of adults. Systemic hyperten-
sion is a risk factor. Screening for IA in certain high-
risk groups, such as patients with coarctation of the
aorta, has been discussed in international guidelines.
Patients with coarctation often have concomitant sys-
temic hypertension. Moreover, the prevalence of hyper-
tension in patients with coarctation and IA is
significantly higher than those without IA. It is uncer-
tain whether hypertension alone represents a sufficient
risk factor to prompt screening for IAs.
Methods
Consecutive patients referred from our tertiary hyperten-
sion clinic underwent comprehensive magnetic resonance
assessment including CMR and 3D time-of-flight MRA
imaging at 1.5T. The study was conducted in accordance
with The Governance Arrangements for Research Ethics
Committees. Cerebral MRAs were double reported by a
blinded Neuroradiologist. Demographic data, including
presentation office systolic (SBP) and diastolic blood pres-
sures (DBP), aneurysm data and CMR-derived left ventri-
cular mass (LVM) indexed to body surface area, age and
gender were recorded. Continuous variables were com-
pared by Student t tests and categoric variables by Fisher
exact test (p<0.05 = significant).
Results
One hundred and twenty one (n=121) MRAs were
included (52% male, mean age 52±14.6 years). IAs were
detected in 10 patients (8.2%) (table 1), significantly
more than expected in the general population on the
basis of 2% prevalence (p<0.05) and similar to the coarc-
tation population (10.3%). Mean aneurysm size was
2.1±0.7mm (range 1-4mm). Subgroup analysis demon-
strated no significant differences between those without
IA (n = 111) and those with IA (n=10) by age (52.0
±14.2 vs 52.3±19.7 years, p=0.9463) or gender (53% vs
40% male, p=0.5176). No difference in prevalence of
hypertension subtype demonstrated between those with-
out IA and those with IA (resistant: 45% vs 30%, p =
0.5103, difficult to treat: 12.6% vs 20%, p=0.3369, drug
intolerant: 14.4% vs 30%, p=0.1913, young-onset: 18.9%
vs 10%, p=0.6874, medication-controlled: 9% vs 10%,
p=0.999). Inferred hypertension severity and chronicity
was similar between those without IA and with IA (SBP:
171.9±28.6 vs 158.8±35.5 mmHg, p=0.1768, DBP:
97.7±14.9 vs 91.4±16.8 mmHg, p=0.2066 and indexed
LV mass: 88.2±24.8 vs 87.6±25.5 g.m-2 p=0.9375, num-
ber of antihypertensive medications: 3.0±2.0 vs 2.6±1.6
p=0.5015).
Conclusions
The prevalence of IA in this cohort is significantly higher
than the general population. Subgroup analysis failed to
identify particularly high-risk groups within the hyper-
tension cohort studied. All aneurysms detected were
small and managed conservatively, consequently the clin-
ical benefit of routine screening for IAs at the time of
CMR in hypertensive patients remains unanswered.
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Table 1 Details of aneurysm and patient demographics.
Site of aneurysm Size (mm) Genger Age (years)
Right MCA 1-2 Male 47
Right ICA bifurcation 2 Female 52
Right ACA 2 Male 58
Left PCom 2 Female 74
Right distal ICA 4 Female 81
Basilar tip 2 Female 45
Left MCA 2 Female 75
Left MCA 2 Male 39
Right SCA 2 Male 26
Basilar tip 2 Female 26
MCA = middle cerebral artery, ICA = internal carotid artery, ACA = anterior
communicating artery, PCom = posterior communicating artery, SCA =
superior cerebellar artery, PCA = posterior cerebellar.
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